XShares Advisors LLC launched five exchange-traded funds on the New York Stock Exchange on Tuesday, with each one targeting a specific segment of the health care, life science and biotechnology industries.

Each ETF will track an index of 22 to 25 stocks.

XShares said the new ETFs take a "vertical" approach to sector investing, allowing investors to focus on diagnosing or treatment of specific diseases.